2-cyano-3-cyclopropyl-3-hydroxy-n-aryl-thioacrylamide Derivatives

Abstract

A compound of the formula (I) or a tautomeric isoform thereof wherein R1 is selected from the group consisting of halogen, nitro, lower alkyl sulfonyl, cyano, trifluromethyl lower alkyl, lower alkoxy, lower alkoxycarbonyl, carboxy, lower alkyl aminosulfonyl, perfluoro lower alkyl, lower alkylthio, hydroxy lower alkyl, alkoxy lower alkyl, lower alkylthio lower alkyl, lower alkylsulfinyl lower alkyl, lower alkylsulfonyl lower alkyl, lower alkylsulfonyl, lower alkanoyl, aroyl, aryl, aryloxy and R2 is selected from the group consisting of hydrogen, alkyl, alkoxy, alkylthio, and alkylcarbonyl, and their non-toxic, pharmaceutically acceptable base addition salts or pro-drugs thereof. The compounds of the invention are useful in the treatment of nervous system diseases and disorders, which are responsive to modulation of the GABAA receptor complex.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 12, 2019
  • Application: Mar 15, 2015
    US US 201515126378 A
  • Priority: Mar 15, 2015
    US US 201515126378 A
  • Priority: Mar 15, 2015
    EP EP 2015055379 W
  • Priority: Mar 18, 2014
    EP EP 14000994 A
  • Priority: Mar 18, 2014
    US US 201461954844 P

Download Citation


Sign in to the Lens

Feedback